Gypsy Moth Management in the United States: a Cooperative Approach
Total Page:16
File Type:pdf, Size:1020Kb
Gypsy Moth Management in the United States: a cooperative approach Draft Supplemental Environmental Impact Statement Risk Assessments and Risk Comparison Volume IV of IV Appendixes J-M United States Department of Agriculture Forest Service Animal and Plant Health Inspection Service Newtown Square, PA NA-MR-01-08 June 2008 Gypsy Moth Management in the United States: a cooperative approach Draft Supplemental Environmental Impact Statement The complete Draft Supplemental Environmental Impact Statement, Gypsy Moth Management in the United States: a cooperative approach, consists of four volumes: Volume I Summary Volume II Chapters 1-8 and Appendixes A, B, C, D, E Volume III Appendixes F, G, H, I Volume IV Appendixes J, K, L, M Lead Agency: Forest Service, U.S. Department of Agriculture (USDA) Responsible Official: James R. Hubbard, Deputy Chief for State and Private Forestry Sidney R. Yates Federal Building 201 14th Street, SW Washington, DC 20250 For More Information: Bill Oldland, SEIS Team Leader 180 Canfield Street Morgantown, WV 26505 Joint Lead Agency: Animal and Plant Health Inspection Service (APHIS), USDA Responsible Official: Richard L. Dunkle, Deputy Administrator for Plant Protection and Quarantine 4700 River Road Riverdale, MD 20737-1236 For More Information: Weyman P. Fussell, Ph.D., Gypsy Moth Program Coordinator Emergency and Domestic Programs, APHIS 4700 River Road, Unit 134 Riverdale, MD 20737-1236 Abstract: The USDA Forest Service and Animal and Plant Health Inspection Service are proposing an addition to the gypsy moth management program that was described in the 1995 Environmental Impact Statement--Gypsy Moth Management in the United States: a cooperative approach--and chosen in the 1996 Record of Decision. The agencies are proposing these new treatment options: adding the insecticide tebufenozide, or adding the insecticide tebufenozide and other new treatment(s) that may become available in the future to manage gypsy moths, provided that the other treatment(s) poses no greater risk to human health and nontarget organisms than are disclosed in this Draft SEIS for the currently approved treatments and tebufenozide. Commenting on this Draft Supplemental Environmental Impact Statement: Reviewers should provide the Forest Service with their comments during the review period of this draft supplemental environmental impact statement. Timely comments will enable the Forest Service to analyze and respond to all of the comments at one time and to use information acquired in the preparation of the final supplemental environmental impact statement, thus avoiding undue delay in the decision making process. Furthermore, the more specific and substantive the comments, the better for reviewers and the agencies alike. Reviewers have an obligation to structure their participation in the National Environmental Policy Act process so that it is meaningful and alerts the agency to the reviewer’s position and contentions (Vermont Yankee Nuclear Power Corp. v. NRDC, 435 U.S. 519, 553, 1978). Environmental objections that could have been raised at the draft stage may therefore be forfeited, if not raised until after completion of the final environmental impact statement (Department ofT ransportation v. Public Citizen, 541 U.S. 752, 764 (2004). Comments on this draft supplemental environmental impact statement should be specific and should address the adequacy of the statement and the merits of the alternatives discussed (40 CFR 1503.3). Web Site for Draft SEIS: The Draft SEIS is available for viewing at www.na.fs.fed.us/wv/eis Send Comments to: Bill Oldland, SEIS Team Leader USDA Forest Service 180 Canfield Street Morgantown, WV 26505 304-285-1585 Date Comments Must Be Received: See cover letter for the date that comments are due in Morgantown, WV. Contents Appendix J. Tebufenozide Risk Assessment Appendix K. DDVP (Dichlorvos) Risk Assessment Appendix L. Gypsy Moth Risk Assessment Appendix M. Risk Comparison Figures Figure J-1. DDT was applied using airplanes in the early years of gypsy moth control programs. Figure K-1. A sprayer unit mounted on a Model A Ford truck was used for gypsy moth control. Figure L-1. Gypsy moth caterpillars cluster at the base of a banded tree (Arlington, Virginia, 1905). Figure M-1. Ropes were used to climb trees, to treat them for gypsy moths in the 1930s. Photo Credits Figure J-1. (UGA1275035) USDA Forest Service Archives, www.forestryimages.org Figure K-1. (UGA1275022) USDA Forest Service Archives, www.forestryimages.org Figure L-1. (UGA1275074) USDA Forest Service Archives, www.forestryimages.org Figure M-1. (UGA1275057) USDA Forest Service Archives, www.forestryimages.org Appendix J Tebufenozide Risk Assessment Figure J-1. DDT was applied using airplanes in the early years of gypsy moth control programs. SERA TR 04-43-05-06c Control/Eradication Agents for the Gypsy Moth - Human Health and Ecological Risk Assessment for Tebufenozide (Mimic) Final Report Prepared for: USDA, Forest Service Forest Health Protection GSA Contract No. GS-10F-0082F USDA Forest Service BPA: WO-01-3187-0150 Requisition No.: 43-3187-1-0269 Task No. 5 Submitted to: Dave Thomas, COTR Forest Health Protection Staff USDA Forest Service Rosslyn Plaza Building C, Room 7129C 1601 North Kent Street Arlington, VA 22209 Prepared by: Patrick R. Durkin and Julie Klotzbach Syracuse Environmental Research Associates, Inc. 5100 Highbridge St., 42C Fayetteville, New York 13066-0950 Telephone: (315) 637-9560 Fax: (315) 637-0445 E-Mail: [email protected] Home Page: www.sera-inc.com August 8, 2004 TABLE OF CONTENTS TABLE OF CONTENTS.......................................................ii LIST OF APPENDICES ......................................................vi LIST OF TABLES...........................................................vi LIST OF FIGURES..........................................................vi LIST OF WORKSHEETS.....................................................vi ACRONYMS, ABBREVIATIONS, AND SYMBOLS . vii COMMON UNIT CONVERSIONS AND ABBREVIATIONS . ix CONVERSION OF SCIENTIFIC NOTATION .................................... x EXECUTIVE SUMMARY.................................................... xi 1. INTRODUCTION......................................................... 1-1 2. PROGRAM DESCRIPTION ................................................ 2-1 2.1. OVERVIEW ..................................................... 2-1 2.2. CHEMICAL DESCRIPTION AND COMMERCIAL FORMULATIONS . 2-1 2.3. APPLICATION METHODS......................................... 2-2 2.4. MIXING AND APPLICATION RATES................................ 2-3 2.5. USE STATISTICS................................................. 2-4 3. HUMAN HEALTH RISK ASSESSMENT ..................................... 3-1 3.1. HAZARD IDENTIFICATION ....................................... 3-1 3.1.1. Overview. ................................................ 3-1 3.1.2. Mechanism of Action........................................ 3-1 3.1.3. Kinetics and Metabolism..................................... 3-1 3.1.3.1. Pharmacokinetic Studies.............. ..... 3-2 3.1.32. Dermal Absorption Rates.......................... 3-2 3.1.4. Acute Oral Toxicity......................................... 3-3 3.1.5. Subchronic or Chronic Systemic Toxic Effects. 3-3 3.1.6. Effects on Nervous System. .................................. 3-4 3.1.7. Effects on Immune System. .................................. 3-4 ii TABLE OF CONTENTS (continued) 3.1.8. Effects on Endocrine System.................................. 3-5 3.1.9. Reproductive and Teratogenic Effects. 3-6 3.1.10. Carcinogenicity and Mutagenicity. 3-6 3.1.11. Irritation and Sensitization (Effects on the Skin and Eyes). 3-7 3.1.12. Systemic Toxic Effects from Dermal Exposure. 3-7 3.1.13. Inhalation Exposure........................................ 3-8 3.1.14. Inerts and Adjuvants. ...................................... 3-8 3.1.15. Impurities and Metabolites................................... 3-9 3.1.16. Toxicologic Interactions. ................................... 3-9 3.2. EXPOSURE ASSESSMENT ....................................... 3-10 3.2.1. Overview. ............................................... 3-10 3.2.2. Workers................................................. 3-10 3.2.2.1. General Exposures................................. 3-11 3.2.2.2. Accidental Exposures............................... 3-12 3.2.3. General Public............................................ 3-14 3.2.3.1. General Considerations . 3-14 3.2.3.2. Direct Spray...................................... 3-14 3.2.3.3. Dermal Exposure from Contaminated Vegetation . 3-14 3.2.3.4. Contaminated Water ............................... 3-15 3.2.3.4.1. Accidental Spill..................... 3-15 3.2.3.4.2. Accidental Direct Spray .................... 3-15 3.2.3.5. Oral Exposure from Contaminated Fish . 3-19 3.2.3.6. Oral Exposure from Contaminated Vegetation . 3-20 3.3. DOSE-RESPONSE ASSESSMENT.................................. 3-23 3.3.1. Overview................................................ 3-23 3.3.2. Chronic RfD............................................. 3-23 3.3.3. Acute RfD............................................... 3-24 3.4. RISK CHARACTERIZATION...................................... 3-26 3.4.1. Overview................................................ 3-26 3.4.2. Workers................................................. 3-26 3.4.3. General Public............................................ 3-27 3.4.4. Sensitive Subgroups........................................ 3-28 3.4.5. Connected Actions........................................